Am J Kidney Dis. 2009 May;53(5):737-40.

C-reactive protein, statins, and cardiovascular risk: what can JUPITER teach us?

Source

General Internal Medicine Section, San Francisco VA Medical Center (111A1), University of California San Francisco, San Francisco, CA 94121, USA.

Comment on

N Engl J Med. 2008 Nov 20;359(21):2195-207.

PMID:: 19393472; [PubMed]

Publication Types

Comment

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk. [Future Cardiol. 2009]
Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk.
Stewart RA. Future Cardiol. 2009 May; 5(3):231-6.
Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study. [Expert Rev Cardiovasc Ther. 2009]
Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study.
Fonseca FA, Izar MC. Expert Rev Cardiovasc Ther. 2009 Sep; 7(9):1041-56.
Review Moving toward new statin guidelines in a post-JUPITER world: principles to consider. [Curr Atheroscler Rep. 2009]
Review Moving toward new statin guidelines in a post-JUPITER world: principles to consider.
Ridker PM. Curr Atheroscler Rep. 2009 Jul; 11(4):249-56.
Review The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease. [Ther Adv Cardiovasc Dis. 2009]
Review The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.
Kones R. Ther Adv Cardiovasc Dis. 2009 Aug; 3(4):309-15. Epub 2009 May 21.
Review The gravity of JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin). [Postgrad Med. 2009]
Review The gravity of JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin).
O'Keefe JH, Carter MD, Lavie CJ, Bell DS. Postgrad Med. 2009 May; 121(3):113-8.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

C-reactive protein, statins, and cardiovascular risk: what can JUPITER teach us?
C-reactive protein, statins, and cardiovascular risk: what can JUPITER teach us?
Am J Kidney Dis. 2009 May ;53(5):737-40.

PubMed
Surgical debridement and adjunctive hyperbaric oxygen in cervical necrotizing fa...
Surgical debridement and adjunctive hyperbaric oxygen in cervical necrotizing fasciitis.
Otolaryngol Head Neck Surg. 2009 May ;140(5):730-4.

PubMed
[Treatment of a serious autistic disorder in a child with Naltrexone in an oral ...
[Treatment of a serious autistic disorder in a child with Naltrexone in an oral suspension form].
Encephale. 2009 Apr ;35(2):168-72. Epub 2008 Jul 7 .

PubMed
[Cognitive remediation and cognitive assistive technologies in schizophrenia].
[Cognitive remediation and cognitive assistive technologies in schizophrenia].
Encephale. 2009 Apr ;35(2):160-7. Epub 2008 Jun 2 .

PubMed
[How to differentiate schizophrenia from bipolar disorder using cognitive assess...
[How to differentiate schizophrenia from bipolar disorder using cognitive assessment?].
Encephale. 2009 Apr ;35(2):139-45. Epub 2008 Sep 23 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

C-reactive protein, statins, and cardiovascular risk: what can JUPITER teach us?

Source

Comment on

Publication Types

Publication Types

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information